Pro-inflammatory HDL in women with obesity and nonalcoholic steatohepatitis

Obes Res Clin Pract. 2020 Jul-Aug;14(4):333-338. doi: 10.1016/j.orcp.2020.06.002. Epub 2020 Jun 25.

Abstract

Background: Individuals with non-alcoholic fatty liver disease (NAFLD), which includes non-alcoholic steatohepatitis (NASH), are at increased risk for cardiovascular events, independent of traditional risk factors. Limited data on pro-inflammatory high density lipoprotein (HDL) in NASH exists in the literature. We hypothesized that HDL from individuals with NASH would be more pro-inflammatory than HDL from individuals without NASH.

Methods: Study participants were individuals with obesity who had undergone bariatric surgery with wedge liver biopsy. Using HDL isolated from serum obtained from study participants at the time of surgery, HDL-elicited macrophage cytokine expression (TNF-α, IL-1β, and IL-6) from THP-1 macrophages, HDL-associated receptor expression (ABCA1 and ABCG1) from apolipoprotein E deficient (apo E-/-) mouse peritoneal macrophages, and isolevuglandin (isoLG) modified HDL were measured.

Results: 11 women with NASH and 15 women without NASH were included in the study. Both TNF-α (P = 0.032) and IL-1β (P = 0.029) were significantly more expressed by THP-1 macrophages exposed to HDL from women with NASH compared to women without NASH. ABCA1 and ABCG1 expression by apo E-/- mouse peritoneal macrophages was not significantly different when exposed to HDL from either women with NASH or women without NASH. IsoLG-modified HDL isolated from the serum of women with NASH trended higher than women without NASH.

Conclusion: Our study suggests a more pro-inflammatory HDL in women with obesity and NASH compared to women with obesity and without NASH.

Keywords: Dysfunctional HDL; IL-1β; Isolevuglandin; Non-alcoholic steatohepatitis; TNF-α.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Bariatric Surgery*
  • Diabetes Mellitus, Type 2*
  • Female
  • Humans
  • Lipoproteins, HDL*
  • Liver
  • Mice
  • Non-alcoholic Fatty Liver Disease*
  • Obesity

Substances

  • Lipoproteins, HDL